Fecal Therapy Shows Survival Benefit in Severe Alcoholic Hepatitis Improved markers of disease severity as well in small trial of steroid-ineligible patients Nov 18, 2024
Alarming Surge in Alcohol-Related Liver Transplants in Younger Adults Targeted preventive strategies needed, especially for younger women, researchers say Nov 14, 2024
GLP-1 Drugs Could Help People With Alcohol Use Disorder Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations Nov 13, 2024
FDA Rejects Full Approval of Liver Disease Drug Agency's decision on obeticholic acid in PBC follows negative advisory committee meeting Nov 12, 2024
Do GLP-1 Agonists Really Need to Be Stopped Before Endoscopy? Meta-analysis suggests 24-hour clear liquid diet works to avoid aspiration, even with GLP-1s Nov 05, 2024
ACG Roundup: Young-Onset Barrett's Esophagus on the Rise Selected highlights from the 2024 American College of Gastroenterology annual meeting Nov 04, 2024
Rifaximin Reduced Overt Hepatic Encephalopathy Recurrence Over Lactulose Rifaximin also reduced mortality, but its high cost may be a barrier Nov 01, 2024
AI Colonoscopies: More Benign Lesion Removals, Potentially Higher Costs At scale, the benefits of AI-assisted colonoscopy may not always outweigh the costs Oct 31, 2024
Novel Drug Improved Symptoms in Eosinophilic Esophagitis Monoclonal antibody cendakimab also reduced eosinophils compared with placebo Oct 30, 2024
Colorado Teen Fights Kidney Failure After Eating McDonald's Quarter Pounders Deadly E. coli outbreak has been tentatively traced to contaminated onions Oct 30, 2024
Low-Volume Bowel Prep Matches Standard for Inpatient Colonoscopy Patients also found MoviPrep to be more tolerable and were more willing to repeat it Oct 29, 2024
Blood Test for CRC Screening Lags Behind Other Options in Cost-Effectiveness Study Fewer cancers, cancer deaths prevented; higher cost per quality-year saved Oct 28, 2024
At Least 75 People Sickened as Deadly McDonald's E. Coli Outbreak Expands Nearly two dozen people have been hospitalized Oct 25, 2024
Algorithm May Be Able to Predict HCC Risk in Advanced Chronic Liver Disease Easy to apply, uses parameters commonly measured in outpatient and inpatient settings Oct 25, 2024
Are Spicy Foods Dangerous to Your Organs? Spicy foods may have health benefits, but they also carry some risk Oct 24, 2024
A Look at Food-Related Illnesses at Restaurants Over the Years While pretty rare for well-known restaurant chains, they do happen Oct 23, 2024
How Do Younger People Fare With Stool Tests for CRC Screening? Retrospective study answers questions raised in shift to screening at age 45 Oct 21, 2024
Rainfall and Mortality; Identifying Risk for Preeclampsia Also in TTHealthWatch: HIV-positive kidney donors Oct 19, 2024 podcast
Novel Targeted Drug Approved for Stomach Cancers Zolbetuximab indicated alongside fluoropyrimidine- and platinum-containing chemotherapy Oct 18, 2024
Novel Drug Maintained Clinical Improvements in IBD Greater benefit seen with higher dose of tulisokibart at week 50 Oct 16, 2024
Allele May Heighten Risk of Severe Ulcerative Colitis Finding on HLA-DRB1*01:03 supports need for more and earlier genetic studies Oct 15, 2024
Novel Drug Effective Against MASH in Phase II Trial Fatty acid synthase inhibitor targets main drivers of liver injury Oct 14, 2024
Some Cancers Occur More Frequently in Multiple Sclerosis Patients Bladder, brain, and cervical cancer risks were higher in people with MS Oct 09, 2024
Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group Rates rose after USPSTF recommendation, but increase was uneven Oct 03, 2024
What Skin Says About Health Knowing what to look for can mean the difference between life and death Oct 03, 2024
Food Retention Risk Low for GLP-1 Users When Endoscopy Is Combined With Colonoscopy Bowel preparation protocols appeared protective in small study Oct 01, 2024
H. Pylori Testing Did Not Reduce Gastric Cancer Incidence, Mortality Gastric cancer incidence was lower after adjusting for certain factors in post hoc analyses Sep 30, 2024
No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says Despite problematic dataset, risk/benefit profile not favorable with PD-L1 expression below 1 Sep 27, 2024
Placebos Linked to Potential Harms in IBD Clinical Trials Alternative designs needed, researchers caution Sep 26, 2024
Timely Skin Cancer Screening After Organ Transplant Still Lacking Only a minority of patients adhered to SUNTRAC screening recommendations Sep 26, 2024
Novel Monoclonal Antibody Shows Promise in Ulcerative Colitis 26% of patients receiving tulisokibart achieved clinical remission vs 1% with placebo Sep 25, 2024
Immunotherapy May Not Benefit All Gastroesophageal Cancer Patients, FDA Staff Says Data since approvals suggest benefits limited to subgroups with PD-L1 expression of at least 1% Sep 24, 2024
FDA Rejects NK1R Antagonist for Gastroparesis Drugmaker none-too-pleased with agency's request for additional studies Sep 19, 2024
GLP-1 Drugs in MASLD Tied to Lower Risk of Cirrhosis, Death Limited benefit seen in patients with established cirrhosis, however Sep 16, 2024
Another Possible Treatment Option for Intermediate-Stage Liver Cancer Adding lenvatinib, pembrolizumab to TACE significantly improved PFS, numerically improved OS Sep 16, 2024
Approved Liver Disease Drug Has No Clinical Benefit, FDA Panel Says Agency advisors put their foot down on shaky science for Ocaliva in primary biliary cholangitis Sep 13, 2024
HHS Proposes Rule to Increase Access to Kidney, Liver Transplants in HIV Patients Rule would streamline criteria for organ donation from donors with HIV to recipients with HIV Sep 13, 2024
